Publicación:
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19

dc.creatorBanerjee, Aditi
dc.creatorCzinn, Steven J.
dc.creatorReiter, Russel J.
dc.creatorBlanchard, Thomas G.
dc.date.accessioned2020-08-20T22:26:12Z
dc.date.available2020-08-20T22:26:12Z
dc.date.created2020-08-15
dc.description.abstractenglishThe outbreak of COVID-19 caused by 2019–nCov/SARS-CoV-2 has become a pandemic with an urgent need for understanding the mechanisms and identifying a treatment. Viral infections including SARS-CoV are associated with increased levels of reactive oxygen species, disturbances of Ca++ caused by unfolded protein response (UPR) mediated by endoplasmic reticulum (ER) stress and is due to the exploitation of virus's own protein i.e., viroporins into the host cells. Several clinical trials are on-going including testing Remdesivir (anti-viral), Chloroquine and Hydroxychloroquine derivatives (anti-malarial drugs) etc. Unfortunately, each drug has specific limitations. Herein, we review the viral protein involvement to activate ER stress transducers (IRE-1, PERK, ATF-6) and their downstream signals; and evaluate combination therapies for COVID-19 mediated ER stress alterations. Melatonin is an immunoregulator, anti-pyretic, antioxidant, anti-inflammatory and ER stress modulator during viral infections. It enhances protective mechanisms for respiratory tract disorders. Andrographolide, isolated from Andrographis paniculata, has versatile biological activities including immunomodulation and determining SARS-CoV-2 binding site. Considering the properties of both compounds in terms of anti-inflammatory, antioxidant, anti-pyrogenic, anti-viral and ER stress modulation and computational approaches revealing andrographolide docks with the SARS-CoV2 binding site, we predict that this combination therapy may have potential utility against COVID-19.spa
dc.format.extent5 Páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.lfs.2020.117842spa
dc.identifier.issn0024-3205spa
dc.identifier.otherhttps://www.sciencedirect.com/science/article/pii/S0024320520305920spa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/12047
dc.language.isoengspa
dc.publisherLife Sciencesspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.rights.localAcceso restringidospa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subject.keywordCOVID-19spa
dc.subject.keyword2019-nCov/SARS-CoV-2spa
dc.subject.keywordEndoplasmic reticulum stressspa
dc.subject.keywordUnfolded protein responsespa
dc.subject.keywordAndrographolidespa
dc.subject.keywordMelatoninspa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.titleCrosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Crosstalk-between-endoplasmic-reticulum-stress-and-anti-viral-a_2020_Life-Sc.pdf
Tamaño:
444.34 KB
Formato:
Adobe Portable Document Format
Descripción:
Documento reservado

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción: